Coronavirus
European Medicines Agency approves Moderna for use in adolescents
1 min
The European Medicines Agency has given the green light to the use of the vaccine of the pharmaceutical company Moderna in adolescents between 12 and 17 years old. It is the second vaccine after Pfizer's authorised in Europe for this age group.
